145 related articles for article (PubMed ID: 12052500)
1. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay.
Snyder RD; Arnone MR
Mutat Res; 2002 Jun; 503(1-2):21-35. PubMed ID: 12052500
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells.
Snyder RD; Gillies PJ
Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117
[TBL] [Abstract][Full Text] [Related]
3. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
Snyder RD
Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
[TBL] [Abstract][Full Text] [Related]
4. Evidence from studies with intact mammalian cells that merbarone and bis(dioxopiperazine)s are topoisomerase II poisons.
Snyder RD
Drug Chem Toxicol; 2003 Feb; 26(1):15-22. PubMed ID: 12643037
[TBL] [Abstract][Full Text] [Related]
5. Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids.
Snyder RD; Gillies PJ
Food Chem Toxicol; 2003 Oct; 41(10):1291-8. PubMed ID: 12909261
[TBL] [Abstract][Full Text] [Related]
6. Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II.
Snyder RD; Grdina DJ
Cancer Res; 2000 Mar; 60(5):1186-8. PubMed ID: 10728671
[TBL] [Abstract][Full Text] [Related]
7. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II.
Li Y; Luan Y; Qi X; Li M; Gong L; Xue X; Wu X; Wu Y; Chen M; Xing G; Yao J; Ren J
Toxicol Sci; 2010 Dec; 118(2):435-43. PubMed ID: 20855424
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of some intercalating agents in Chinese hamster V79 cells.
O'Donovan MR
Mutat Res; 1984; 137(2-3):117-22. PubMed ID: 6472323
[TBL] [Abstract][Full Text] [Related]
9. Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and II.
Rosenzweig HS; Papadopoulou MV; Bloomer WD
Oncol Res; 2005; 15(4):219-31. PubMed ID: 17822282
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of bleomycin-induced micronucleus formation in V79 cells as a rapid and sensitive screen for non-covalent DNA-binding compounds.
Snyder RD; Strekowski L
Mutat Res; 1999 Jul; 444(1):181-92. PubMed ID: 10477353
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500.
Cummings J; Sumner AT; Slavotinek A; Meikle I; Macpherson JS; Smyth JF
Mutat Res; 1995 Aug; 344(1-2):55-62. PubMed ID: 7565893
[TBL] [Abstract][Full Text] [Related]
12. DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays.
Snyder RD; Ewing D; Hendry LB
Mutat Res; 2006 Oct; 609(1):47-59. PubMed ID: 16857419
[TBL] [Abstract][Full Text] [Related]
13. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells.
Jones NJ; Ellard S; Waters R; Parry EM
Carcinogenesis; 1993 Dec; 14(12):2487-94. PubMed ID: 8269616
[TBL] [Abstract][Full Text] [Related]
14. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
15. Evidence for and role of the dimethylamino group in tamoxifen DNA intercalation in intact Chinese hamster V79 cells.
Snyder RD; Brown JE
Drug Chem Toxicol; 2002 Nov; 25(4):473-9. PubMed ID: 12378953
[TBL] [Abstract][Full Text] [Related]
16. Assessment of atypical DNA intercalating agents in biological and in silico systems.
Snyder RD
Mutat Res; 2007 Oct; 623(1-2):72-82. PubMed ID: 17434187
[TBL] [Abstract][Full Text] [Related]
17. MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poison.
Xie CY; Zhu H; Lin LP; Miao ZH; Geng MY; Cai YJ; Chen Y; Zhao HJ; Luo HB; Zhang XW; Fan LM; Shen YM; Ding J
Mol Cancer Ther; 2007 Nov; 6(11):3059-70. PubMed ID: 18025289
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the mutagenicity and recombinagenicity of bleomycin in yeast by unconventional intercalating agents.
Hoffmann GR; Laterza AM; Sylvia KE; Tartaglione JP
Environ Mol Mutagen; 2011 Mar; 52(2):130-44. PubMed ID: 20839230
[TBL] [Abstract][Full Text] [Related]
19. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
Meng LH; Zhang JS; Ding J
Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
[TBL] [Abstract][Full Text] [Related]
20. AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex.
Marshall KM; Holden JA; Koller A; Kashman Y; Copp BR; Barrows LR
Anticancer Drugs; 2004 Oct; 15(9):907-13. PubMed ID: 15457132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
